The diabetes tech company raised its expectations for revenue and gross margins, despite the impact of tariffs.

The DNA sequencing company also cut its 2025 earnings outlook to reflect the impact of tariffs on its business.

The company plans to launch the lens, which supports vision at all distances, in Europe in the coming weeks.

Commissioner Martin Makary also said the agency would roll out a generative AI system across its centers that will help FDA ...

Ebekozien, chief quality officer of the American Diabetes Association, said the nonprofit is seeing a shift with more devices ...